newdrugapprovals.org
FDA approves new treatment Xeljanz (tofacitinib) for moderately to severely active ulcerative colitis
FDA approves new treatment for moderately to severely active ulcerative colitis The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with mod…